Cozad Asset Management Inc. Purchases 81 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cozad Asset Management Inc. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,709 shares of the healthcare conglomerate’s stock after purchasing an additional 81 shares during the period. UnitedHealth Group comprises 1.1% of Cozad Asset Management Inc.’s portfolio, making the stock its 22nd biggest position. Cozad Asset Management Inc.’s holdings in UnitedHealth Group were worth $11,488,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $40,000. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $488.52 on Monday. The stock has a market cap of $446.85 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a 50-day simple moving average of $511.36 and a 200-day simple moving average of $549.80.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.83 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.